ZA948357B - Potentiation of drug response - Google Patents

Potentiation of drug response

Info

Publication number
ZA948357B
ZA948357B ZA948357A ZA948357A ZA948357B ZA 948357 B ZA948357 B ZA 948357B ZA 948357 A ZA948357 A ZA 948357A ZA 948357 A ZA948357 A ZA 948357A ZA 948357 B ZA948357 B ZA 948357B
Authority
ZA
South Africa
Prior art keywords
potentiation
drug response
drug
response
Prior art date
Application number
ZA948357A
Inventor
David Taiwai Wong
Juan Ignacio Oguiza
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of ZA948357B publication Critical patent/ZA948357B/en

Links

ZA948357A 1994-06-16 1994-10-24 Potentiation of drug response ZA948357B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US26085794A 1994-06-16 1994-06-16

Publications (1)

Publication Number Publication Date
ZA948357B true ZA948357B (en) 1996-04-24

Family

ID=22990926

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA948357A ZA948357B (en) 1994-06-16 1994-10-24 Potentiation of drug response

Country Status (2)

Country Link
RU (1) RU94037967A (en)
ZA (1) ZA948357B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR042806A1 (en) 2002-12-27 2005-07-06 Otsuka Pharma Co Ltd COMBINATION OF CARBOSTIRILE DERIVATIVES AND INHIBITORS OF SEROTONINE REABSORTION FOR THE TREATMENT OF ANIMO DISORDERS
MXPA05006857A (en) 2002-12-27 2005-08-18 Otsuka Pharma Co Ltd Carbostyril derivatives and serotonin reuptake inhibitors for treatment of mood disorders.

Also Published As

Publication number Publication date
RU94037967A (en) 1996-08-27

Similar Documents

Publication Publication Date Title
HU9403071D0 (en) Potentiation of drug response
HUP9801151A3 (en) Long-shelf-life medicaments
GB9517022D0 (en) Medicaments
EP0850057A4 (en) Pharmaceutical compounds
GB9508823D0 (en) Drug Derivatives
GB9526392D0 (en) Medicaments
GB9506844D0 (en) Pharmaceutical microencapsulation
AP9801196A0 (en) Pharmaceutical preparation
GB9503850D0 (en) Medicaments
SG47206A1 (en) Pharmaceutical compounds
ZA948357B (en) Potentiation of drug response
ZA967542B (en) Pharmaceutical combination preparation comprising keto-profen
GB9523066D0 (en) Compounds and their therapeutic use
GB9505679D0 (en) New pharmaceutical use
GB9505678D0 (en) New pharmaceutical use
GB9503709D0 (en) New pharmaceutical use
GB9522632D0 (en) New pharmaceutical use
GB9502542D0 (en) Novel pharmaceutical use
GB9523453D0 (en) Medicaments
GB9515628D0 (en) Medicaments
GB9521208D0 (en) Medicaments
IL127776A0 (en) Medicaments
GB9504153D0 (en) Medicaments
GB9519585D0 (en) Medicaments
GB9506122D0 (en) Medicaments